Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

Sam Altman, the CEO of OpenAI, is reportedly extending his influence into the realm of hardware-focused AI innovations by ...

The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...

A year after Neuralink secured FDA approval to test brain implants designed to restore sight, one of its earliest patients has found another use for the ...

AI may help radiologists evaluate mammograms for breast cancer more effectively, but researchers at UCLA, UC Davis and ...

The tech division of the Mitsubishi Group will demonstrate systems that are due to make production in the coming years.

Synchron was spun out of University of Melbourne by cofounders Dr Tom Oxley, Prof Nicholas Opie, and Dr Rahul Sharma in 2012.

However, the rapid development of AI-driven technology brings new risks, creating demand for updated regulations and ...

AI can now turn brain scans into text. It’s not mind reading but it’s pretty close.